In our case, however, our patient was finally diagnosed not as having nivolumab-induced myositis but as having paraneoplastic dermatomyositis because of the time course of redness of skin and the high anti-TIF1-γ antibody titer. This evidence concerns the gene TRIM24 and myositis disease.